Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Robert G. Wadleigh"'
Autor:
Hayriye Verda Erkizan, Shrey Sukhadia, Thanemozhi G. Natarajan, Gustavo Marino, Vicente Notario, Jack H. Lichy, Robert G. Wadleigh
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Esophageal cancer has a strikingly low survival rate mainly due to the lack of diagnostic markers for early detection and effective therapies. In the U.S., 75% of individuals diagnosed with esophageal squamous cell carcinoma (ESCC) are of Af
Externí odkaz:
https://doaj.org/article/ca8d62a5f3954af2b113cef1574f176b
Autor:
Hayriye Verda Erkizan, Kory Johnson, Svetlana Ghimbovschi, Deepa Karkera, Gregory Trachiotis, Houtan Adib, Eric P. Hoffman, Robert G. Wadleigh
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background Esophageal carcinoma is the third most common gastrointestinal malignancy worldwide and is largely unresponsive to therapy. African-Americans have an increased risk for esophageal squamous cell carcinoma (ESCC), the subtype that s
Externí odkaz:
https://doaj.org/article/7ab688e390594178ab1dd5d0310cf450
Autor:
Shrey Sukhadia, Gustavo Marino, Robert G. Wadleigh, Thanemozhi G. Natarajan, Vicente Notario, Hayriye V. Erkizan, Jack H. Lichy
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
Esophageal cancer has a strikingly low survival rate mainly due to the lack of diagnostic markers for early detection and effective therapies. In the U.S., 75% of individuals diagnosed with esophageal squamous cell carcinoma (ESCC) are of African des
Autor:
Hayriye V. Erkizan, Robert G. Wadleigh
Publikováno v:
Cancer Research. 81:592-592
Background: The availability of circulating tumor cells (CTCs) creates a powerful non-invasive approach to monitor tumor progression, therapeutic response, relapse, metastasis, and, in some cases, provide early diagnosis. Esophageal cancer (EC) is th
Autor:
Gregory D. Trachiotis, Eric P. Hoffman, Svetlana Ghimbovschi, Kory Johnson, Robert G. Wadleigh, Houtan Adib, Deepa J. Karkera, Hayriye V. Erkizan
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-13 (2017)
BMC Cancer
BMC Cancer
Background Esophageal carcinoma is the third most common gastrointestinal malignancy worldwide and is largely unresponsive to therapy. African-Americans have an increased risk for esophageal squamous cell carcinoma (ESCC), the subtype that shows mark
Autor:
Suman Chauhan, Gustavo Marino, Nirmala Akula, Robert G. Wadleigh, Hayriye V. Erkizan, Edina Paal, Jack H. Lichy, Susan Lazerow, Min-Ling Liu
Publikováno v:
Journal of Clinical Oncology. 38:e16552-e16552
e16552 Background: Esophageal cancer (EC) is one of the most lethal cancers with 90% mortality rate. Uneven Worldwide geographical distribution and varying etiologic factors contribute to the heterogenic nature of EC worldwide. In the US, 75% esophag
Autor:
Yuriy Gusev, Krithika Bhuvaneshwar, Jack H. Lichy, Robert G. Wadleigh, Gustavo Marino, Vincente Notario, Hayriye V. Erkizan
Publikováno v:
Cancer Research. 78:3426-3426
Background: Esophageal carcinoma (EC) is one of the most common malignancies of the gastrointestinal tract worldwide and is unresponsive to therapy. Esophageal squamous cell carcinoma (ESCC) comprises the majority of EC in African Americans, Asians a
Publikováno v:
Cancer Research. 77:5566-5566
Background: Esophageal carcinoma is the third most common gastrointestinal malignancy worldwide and is largely unresponsive to therapy. African-Americans have an increased risk for esophageal squamous cell carcinoma (ESCC), this subtype that shows a
Autor:
Svetlana Pack, Robert G. Wadleigh, Wong Sang Park, Kannan V. Balan, Jayaprakash D. Karkera, Moshe Glaser, Lance A. Liotta, Thu Anh Pham, Patrick Hwu, David O. Ault, Evgenia Pak, Zhengping Zhuang, Sevilla D. Detera-Wadleigh
Publikováno v:
Genes, Chromosomes and Cancer. 25:160-168
Esophageal cancer is the third most prevalent gastrointestinal malignancy in the world. The tumor responds poorly to various therapeutic regimens and the genetic events underlying esophageal carcinogenesis are not well understood. To identify overall
Publikováno v:
Clinical advances in hematologyoncology : HO. 11(1)